Literature DB >> 2164359

Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes.

K Kragballe1, I L Wildfang.   

Abstract

The hormonally active form of vitamin D3, 1,25-dihydroxy vitamin D3 [1,25-(OH)2-D3; calcitriol], regulates the differentiation and proliferation of epidermal keratinocytes in vitro. MC 903 (calcipotriol) is a novel vitamin D3 analogue which is at least 100 times less potent than 1,25-(OH)-2-D3 in its effects on calcium homeostasis. The present study compared the effects of MC 903 and 1,25-(OH)2-D3 on terminal differentiation and proliferation of cultured normal human keratinocytes. Keratinocytes were grown in McCoy's 5A medium supplemented with penicillin (50 IU/ml), streptomycin (50 micrograms/ml), L-serine (4 X 10(-4) M), and 10% human type AB serum. MC 903, 1,25-(OH)2-D3 or 1 alpha-OH-D3 (10(-12) M--10(-8) M) was added with each feeding when cultures became preconfluent. After incubation for 24 h with D3 vitamins, cultures were extracted for transglutaminase, and the enzyme activity was indexed against DNA content. The activity of transglutaminase, the enzyme responsible for cross-linking the proteins of the cornified envelope, was maximally stimulated by 388% with MC 903 (10(-8) M), by 328% with 1,25-(OH)2-D3 (10(-8) M), and by 27% with 1 alpha-OH-D3 (10(-8) M) compared with vehicle. After incubation for 2 weeks the number of keratinocytes with cornified envelopes had increased by 288% with MC 903 (10(-8) M), by 360% with 1,25-(OH)2-D3 (10(-8) M), and by 149% with 1 alpha-OH-D3 (10(-8) M) compared with vehicle.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164359     DOI: 10.1007/BF00372616

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  15 in total

1.  Metabolism of 1alpha-hydroxyvitamin D3 to 1alpha, 25-dihydroxyvitamin D3 in perfused rat liver.

Authors:  M Fukushima; Y Suzuki; Y Toira; I Matsunaga; K Ochi; H Nagano
Journal:  Biochem Biophys Res Commun       Date:  1975-09-16       Impact factor: 3.575

2.  Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro.

Authors:  K Kragballe; L Desjarlais; C L Marcelo
Journal:  Br J Dermatol       Date:  1985-03       Impact factor: 9.302

3.  Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study.

Authors:  K Kragballe; H I Beck; H Søgaard
Journal:  Br J Dermatol       Date:  1988-08       Impact factor: 9.302

4.  Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions.

Authors:  E L Smith; N C Walworth; M F Holick
Journal:  J Invest Dermatol       Date:  1986-06       Impact factor: 8.551

5.  Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)

Authors:  K Kragballe
Journal:  Arch Dermatol       Date:  1989-12

6.  Characterization of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin.

Authors:  R U Simpson; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

7.  Isolation and growth of adult human epidermal keratinocytes in cell culture.

Authors:  S C Liu; M Karasek
Journal:  J Invest Dermatol       Date:  1978-08       Impact factor: 8.551

8.  1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation.

Authors:  S Pillai; D D Bikle; P M Elias
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

9.  Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo.

Authors:  L Binderup; E Bramm
Journal:  Biochem Pharmacol       Date:  1988-03-01       Impact factor: 5.858

10.  Stratification, specialization, and proliferation of primary keratinocyte cultures. Evidence of a functioning in vitro epidermal cell system.

Authors:  C L Marcelo; Y G Kim; J L Kaine; J J Voorhees
Journal:  J Cell Biol       Date:  1978-11       Impact factor: 10.539

View more
  18 in total

1.  Calcipotriol affects keratinocyte proliferation by decreasing expression of early growth response-1 and polo-like kinase-2.

Authors:  Jernej Kristl; Petra Slanc; Metka Krasna; Ales Berlec; Matjaz Jeras; Borut Strukelj
Journal:  Pharm Res       Date:  2007-08-02       Impact factor: 4.200

2.  A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis.

Authors:  T A Luger; F Cambazard; F G Larsen; M Bourcier; G Gupta; F Clonier; P Kidson; N H Shear
Journal:  Dermatology       Date:  2008-09-12       Impact factor: 5.366

Review 3.  Psoriasis in children: a guide to its diagnosis and management.

Authors:  J Leman; D Burden
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  From the bench to the clinic: New aspects on immunoregulation by vitamin D analogs.

Authors:  Hekla Sigmundsdottir
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 5.  Psoriasis and Psoriatic Arthritis.

Authors:  Jennifer Clay Cather; Melodie Young; Martin Jan Bergman
Journal:  J Clin Aesthet Dermatol       Date:  2017-03-01

Review 6.  Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment.

Authors:  C J van der Vleuten; P C van de Kerkhof
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 7.  Nonclassic actions of vitamin D.

Authors:  Daniel Bikle
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

8.  Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol.

Authors:  C J van der Vleuten; E M de Jong; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

Review 9.  Vitamin D3 and skin diseases.

Authors:  K Kragballe
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

Review 10.  Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris.

Authors:  D Murdoch; S P Clissold
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.